Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-11 Sale |
2025-02-12 9:27 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
54,244 | $25 | $1,356,100 | 54,410 (Direct) |
View |
| 2025-02-03 Sale |
2025-02-04 8:30 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
3,348 | $20.12 | $67,362 | 89,654 (Direct) |
View |
| 2025-01-22 Sale |
2025-01-23 8:31 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
925 | $18.94 | $17,520 | 54,002 (Direct) |
View |
| 2024-12-26 Sale |
2024-12-27 7:47 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
15,000 | $17.22 | $258,277 | 54,927 (Direct) |
View |
| 2024-11-25 Sale |
2024-11-25 9:00 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
12,090 | $18.3 | $221,258 | 69,927 (Direct) |
View |
| 2024-02-01 Sale |
2024-02-02 4:05 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
2,820 | $8.5312 | $24,058 | 77,017 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-25 4:10 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
910 | $9.0684 | $8,252 | 41,337 (Direct) |
View |
| 2023-05-10 Sale |
2023-05-12 4:06 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer |
558 | $16.49 | $9,200 | 42,247 (Direct) |
View |
| 2023-02-01 Sale |
2023-02-02 6:53 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer |
2,031 | $21.87 | $44,419 | 62,805 (Direct) |
View |
| 2023-01-24 Sale |
2023-01-26 4:05 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer |
1,097 | $21.86 | $23,976 | 34,836 (Direct) |
View |
| 2022-09-13 Sale |
2022-09-15 4:05 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer |
349 | $28 | $9,772 | 35,933 (Direct) |
View |
| 2022-05-10 Sale |
2022-05-12 8:44 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer |
881 | $21.72 | $19,134 | 35,733 (Direct) |
View |
| 2022-01-31 Sale |
2022-02-02 4:22 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra VP, Corp Controller and CAO |
798 | $26.51 | $21,152 | 54,114 (Direct) |
View |
| 2022-01-24 Sale |
2022-01-26 4:38 pm |
Travere Therapeutics Inc. | TVTX | Calvin Sandra VP, Corp Controller and CAO |
934 | $24.58 | $22,955 | 28,662 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-11 Exercise |
2025-02-12 9:27 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
10,000 | $17.96 | 54,410 (Direct) |
View |
| 2025-02-11 Exercise |
2025-02-12 9:27 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
10,000 | $17.44 | 54,410 (Direct) |
View |
| 2025-02-11 Exercise |
2025-02-12 9:27 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
10,000 | $16.23 | 54,410 (Direct) |
View |
| 2025-02-11 Exercise |
2025-02-12 9:27 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
15,000 | $15.46 | 54,410 (Direct) |
View |
| 2025-02-11 Exercise |
2025-02-12 9:27 pm |
N/A 2026-05-19 |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
45,000 | $0 | 54,410 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-04 8:30 pm |
N/A 2035-01-31 |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
39,000 | $0 | 89,654 (Direct) |
View |
| 2024-12-26 Exercise |
2024-12-27 7:47 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
15,000 | $12.67 | 54,927 (Direct) |
View |
| 2024-12-26 Exercise |
2024-12-27 7:47 pm |
N/A 2025-01-02 |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
15,000 | $0 | 54,927 (Direct) |
View |
| 2024-11-25 Exercise |
2024-11-25 9:00 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
15,000 | $12.67 | 69,927 (Direct) |
View |
| 2024-11-25 Exercise |
2024-11-25 9:00 pm |
N/A 2025-01-02 |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
15,000 | $0 | 69,927 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 4:05 pm |
N/A 2034-01-30 |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER |
38,500 | $0 | 77,017 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 6:53 pm |
N/A 2033-01-30 |
Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer |
30,000 | $0 | 62,805 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:22 pm |
N/A 2032-01-30 |
Travere Therapeutics Inc. | TVTX | Calvin Sandra VP, Corp Controller and CAO |
26,250 | $0 | 54,114 (Direct) |
View |
Ownership |
2021-09-23 6:14 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Calvin Sandra VP, Corp Controller and CAO |
0 | $0 | 136,254 (Direct) |
View |